GENTURADX
Molecular diagnostic company focused on making multiplexed molecular testing both affordable and practical for any laboratory to perform. The company’s IDbox™ system and single-use cassette will circumvent long-standing barriers of costs, automation and performance facilitating in-house lab testing for actionable results. In July 2012, GenturaDx was acquired by Luminex Corp. (NASDAQ:LMNX).
GENTURADX
Social Links:
Industry:
Biopharma Medical Medical Device
Founded:
2005-01-01
Address:
Hayward, California, United States
Country:
United States
Status:
Active
Contact:
1(510) 725-4767
Total Funding:
21 M USD
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Founder
Investors List
DT Capital Partners
DT Capital Partners investment in Series C - GenturaDx
Bay City Capital
Bay City Capital investment in Series C - GenturaDx
More informations about "GenturaDx"
Genturadx - LinkedIn
GenturaDx was founded on the idea that molecular diagnostic testing should be simple, affordable and have utility across a broad range of tests. ... Human Genome Organization (HUGO) Non-profit ...See details»
GenturaDx - Crunchbase Company Profile & Funding
Organization. GenturaDx . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. ... In July 2012, GenturaDx. was …See details»
GenturaDx 2025 Company Profile: Valuation, Investors ... - PitchBook
GenturaDx General Information Description. Developer of automated instruments for hospitals and patients in the United States and internationally. The company is a molecular diagnostics …See details»
Luminex Corporation Announces Agreement to Acquire …
AUSTIN, Texas, July 9, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular …See details»
GenturaDx - Bay City Capital
GenturaDx Molecular diagnostic company focused on making multiplexed molecular testing both affordable and practical for any laboratory to perform. The company’s IDbox™ system and …See details»
Genturadx - 2025 Company Profile, Funding & Competitors - Tracxn
May 5, 2025 Genturadx - Molecular diagnostic platforms for clinical applications. Acquired by Luminex. Raised a total funding of $4.01M over 2 rounds from 1 investor. Founded by Steve …See details»
GenturaDx Genetics & Genomics News - GenomeWeb
Luminex Combining EraGen, GenturaDx Techs to Reach HT, Lower-Plex, and LDT Markets Premium Luminex this week provided investors with additional details regarding the planned …See details»
GenturaDx - Headquarter Location, Corporate Office Address and …
GenturaDx is Diagnostic Equipment in United States that focus on products include business. Founded in 2005. They cover business area such as developer, automate instrument, hospital, …See details»
GenturaDx Inc - Company Profile and News - Bloomberg Markets
Company profile page for GenturaDx Inc including stock price, company news, executives, board members, and contact informationSee details»
Genturadx, Hayward CA - Company Profile - BizStanding
The organization Genturadx works in Medical Devices industry. A registered office address of Genturadx is 24590 Clawiter Rd, Hayward, CA 94545. For more information, please visit the …See details»
Luminex Acquires GenturaDX, Inc.; Wins M&A Deal of the Year
The firm assisted Luminex Corporation in its acquisition of Gentura DX, Inc., a BVI Corporation. The acquisition was valued at $50 million. The firm received an “M&A Deal of the Year” award …See details»
GenturaDx - Contacts, Employees, Board Members, Advisors
Molecular diagnostic company focused on making multiplexed molecular testing both affordable and practical for any laboratory to perform.See details»
Luminex Corporation Announces Agreement to Acquire GenturaDx
Jul 9, 2012 GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow. This …See details»
GenturaDx - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2008: Series C - …See details»
GenturaDx IDbox - Ximedica
GenturaDx IDbox CASE STUDY Making molecular diagnostics accessible for more patients and providers by simplifying real-time PCR testing Ximedica partnered with an innovative startup to …See details»
GenturaDx - Drug pipelines, Patents, Clinical trials - Synapse
Explore GenturaDx with its drug pipeline, therapeutic area, technology platform, .See details»
Genturadx Management Team | Org Chart - RocketReach
Genturadx employs 2 employees. The Genturadx management team includes Andrea Crow (Communications), Deborah Wright (VP Ops), and Geoffrey McKinley (VP R and D). Get …See details»
Genturadx Overview | SignalHire Company Profile
GenturaDx was founded on the idea that molecular diagnostic testing should be simple, affordable and have utility across a broad range of tests. Our mission is to create a comprehensive, cost …See details»
Luminex to acquire molecular diagnostics company, GenturaDx
Jul 9, 2012 Please use one of the following formats to cite this article in your essay, paper or report: APA. Luminex. (2019, June 17). Luminex to acquire molecular diagnostics company, …See details»
Luminex Corporation Announces Agreement to Acquire GenturaDx
AUSTIN, Texas, — Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on …See details»